C

Cellectis

Develops allogeneic CAR-T cell therapies

Senior Director - Medical Affairs

Clinical Support & Patient AdministrationConfirmed live in the last 24 hours
Full-timeNew York, NY, USA$175k - $225k /yr

About the Job

Requirements

  • Pharm D or MD with experience in Hematology / Oncology.
  • Fifteen or more years of medical affairs and/or clinical development experience in the biopharmaceutical industry.
  • Demonstrated experience engaging key opinion leaders, therapeutic area experts, payors and patient advocacy organizations.
  • Experience in drug development and/or clinical practice; demonstrated knowledge of the competitive landscape, trends, and physician practices.
  • Skilled at presenting clinical and non-clinical data to external audiences and management teams.
  • Clinical development experience highly preferred.

Responsibilities

  • Partner with the Chief Medical Officer to develop and execute Cellectis' medical affairs strategy.
  • Build and manage medical affairs capabilities including medical strategy, medical communications, publications, and scientific engagement.
  • Provide expert scientific and medical insights across immuno-oncology programs.
  • Lead engagement with key opinion leaders, investigators, and scientific experts.
  • Represent Cellectis at scientific meetings, advisory boards, and congresses.
  • Drive creation of scientific platforms and data-driven communication strategies.
  • Oversee development of medical information, publications, and internal scientific education.
  • Identify and address data gaps through evidence-generation initiatives.
  • Support clinical development and early-access programs with medical expertise.
  • Integrate patient insights into medical and clinical strategies.
  • Partner cross-functionally with clinical development, regulatory and communications affairs to ensure alignment and shared decision-making.
  • Establish governance processes, operational metrics, and reporting frameworks.
  • Promote a culture of scientific rigor, compliance, and patient focus.

Desired Qualifications

  • None

About the Company

Cellectis

Develops allogeneic CAR-T cell therapies

Cellectis develops immunotherapy treatments for cancer using gene-edited allogeneic CAR T cells. Its products rely on donor-derived T cells that are edited to remove T cell receptor activity and engineered to express a chimeric antigen receptor (CAR) that targets cancer cells. The goal is to create off-the-shelf CAR T therapies that are available quickly and at a lower cost than patient-specific (autologous) CAR T treatments. Cellectis works through research and development, clinical trials, and partnerships with other pharma companies, such as Sanofi, and generates revenue from licensing, milestone payments, and potential future product sales. The company differentiates itself by offering off-the-shelf solutions rather than custom-made therapies, aiming to broaden access to advanced cancer treatment.

Company size
201-500
Company stage
IPO
Headquarters
Paris, France
Founded
2000

Recently Posted Jobs

Explore more opportunities at Cellectis

See more jobs